Community-acquired pneumonia: Appropriateness of admissions, risk factors and therapy;Le polmoniti acquisite in comunità: Appropriantezza dei ricoveri, fattori di rischio e terapia adottata

Infezioni in Medicina

Volumn 12, Issue 1, 2004, Pages 34-43

  Libanore, Marco ^a   Bicocchi, Roberto ^a   Pantaleoni, Mario ^a   Antonioli, Maria Paola ^a   Napoli, Nicola ^a   Ghinelli, Florio ^a  

^a Azienda Osp Univ Arcisp S Anna   (Italy)

Author keywords

Community acquired pneumonia; Risk factors

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; NETILMICIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULTAMICILLIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BRAIN DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; FEMALE; GASTROINTESTINAL DISEASE; HEART FAILURE; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; ITALY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SENESCENCE; SYSTEMIC DISEASE; URINARY TRACT DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SERVICES MISUSE; HOME NURSING; HOSPITALIZATION; HUMANS; ITALY; MALE; MIDDLE AGED; PATIENT ADMISSION; PNEUMONIA; RISK FACTORS;

EID: 3342921885     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bartlett J.G., Mundy L.M. Community acquired pneumonia. N. Engl. J. Med. 333, 1618-1624, 1995.
2. Halm E.A., Teirstein A.S. Management of community acquired pneumonia. N. Engl. J. Med. 347, 25, 2039-2045, 2002.
3. MacFarlane J.T. Community acquired pneumonia. Br. J. Dis. Chest 81, 116-127, 1987.
4. Pinner R.W., Teutsch S.M., Simonsen L., et al. Trends in infectious diseases mortality in the United States. JAMA 275, 189-193, 1996.
5. Centers for Disease Control and Prevention. Premature deaths, monthly mortality and monthly physician contacts-United States. MMWR 46, 556, 1997.
6. Marston B.J., Plouffe J.F., File T.M., et al. Incidence of community-acquired pneumonia requiring hospitalizations: results of a population-based active surveillance study in Ohio. Arch. Intern. Med. 157, 1509-1518, 1997.
7. ISTAT: Statistiche della Sanità - Anno 2000, n.6; Roma, 2001.
8. Del Prato B., Bettoncelli G., Neri M. In Infezioni Respiratorie. Ed. Pacini 2001.
9. Torres A., Serra-Battles J., Ferrer A., et al. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am. Rev. Respir. Dis. 144, 312-318, 1991.
10. Metlay J. P., Schulz R., Li Y. H. et al. Influenze of age on symptoms at presentation in patients with community acquired pneumonia. Arch. Intern. Med. 157, 1453-1459, 1997.
11. Houston M.S., Silverstein M.D., Suman V.J. Risk factors for 30 day mortality in elderly patients with lower respiratory tract infection. Arch. Intern. Med 157, 2190-2195, 1997.
12. Conte H.A., Chen Y.T., Mehal W. et al. A prognostic rule for elderly patients admitted with community acquired pneumonia. Am. J. Med. 106, 20-28, 1999.
13. Ewig S., Kleinfeld T., Buer T. et al. Comparative validation of prognostic rules for community acquired pneumonia in an elderly population. Eur. Respir. J. 14, 370-375, 1999.
14. Auble T.E., Yealy D.M., Fine M.J. Assessing prognosis and selecting an initial site of care for adults with community acquired pneumonia. Infect. Dis. North. Am. 12, 741-759, 1998.
15. Marrie T.J., Durant H., Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev. Infect. Dis. 11, 586-599, 1989.
16. Fine M.J., Auble E.T., Yealy D.M. A prediction rule to identify low risk patients with community acquired pneumonia. N. Engl. J. Med. 336, 243-250, 1997.
17. Marrie T.J., Lau C.Y., Wheeler S.L. et al. A controlled trial of a critical pathway for treatment of community acquired pneumonia. JAMA 283, 749-55, 2000.
18. Dean N.C., Suchyta M.R., Bateman K.A. Implementation of admission decision support for community acquired pneumonia. A pilot study. Chest 117, 1368-77, 2000.
19. Bartlett J.G., Breiman R.F., Mandell L.A., et al. Community acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis. 26, 811-838, 1998.
20. [201 Moine P., Vercken J., Chevret S., et al. Severe community-acquired pneumonia: etiology, epidemiology, and prognostic factors. Chest 105, 1487-1495, 1994.
21. Woodhead M. Community-acquired pneumonia guidelines. An international comparison. A view from Europe. Chest 183-187, 1998.
22. Fang G., Fine M., Orloff J., et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine 69, 307-316, 1990.
23. Levy M., Dromer F., Brion N., et al. Community-acquired pneumonia: importance of initial noninvasive bacteriologic and radiographic investigatios. Chest 93, 43-48, 1988.
24. Libanore M., Ghinelli F., Rossi M.R., et al. Percorsi diagnostico-terapeutici delle polmoniti acquisite in comunità: un obiettivo del Piano Sanitario Nazionale recepito dall'Azienda Ospedale - Università di Ferrara. Giornale Italiano Malattie Infettive 5, 3, 295, 1999.
25. Tang C.M., Mac Farlane J.T. Early management of younger adults dying of community-acquired pneumonia. Respir. Med. 87, 289-294, 1993.
26. Bartlett J.G., Dowell S.F., Mandell L.A., File T.M., Musher D.M., Fine M.J. Guidelines from the IDSA. Practice Guidelines for the Management of Community Acquired Pneumonia in Adults. Clin. Infect. Dis. 31, 347-382, 2000.
27. M. Grossman R.F., Chow A.W., Hyland R.H., and Canadian Community Acquired Pneumonia Working Group. Canadian Guidelines for the Initial Management of Community acquired pneumonia: an evidence based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin. Infect. Dis. 31, 383-421, 2000.
28. American Thoracic Society. Guidelines for the management of adults with Community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 1730-1754, 2001.
29. British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults. Thorax 56, 4, 1-64, 2001.
30. Gialdroni Grassi G., Bianchi L. Guidelines for the management of community-acquired pneumonia in adults. Monaldi Arch. Dis. Chest 50, 21-27, 1995.
31. ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur. Respir. J. 11, 986-991, 1998.
32. Blasi F., Bulfoni A., Concia E., et al. Gestione delle infezioni delle basse vie respiratorie in Medicina Interna. Giornale Italiano Medicina Interna 1, 2, 1-23, 2002.
33. Gleason P.P., Meechan T.P., Fine J.M., Galusha D.H., Fine M.J. Association between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch. Intern. Med. 159, 2562-2572, 1999.
34. Fine M.J., Stone R.A., Singer D.E. et al. Processes and outcome of care for patients with community acquired pneumonia: results from the Pneumonia Patients Outcome Research Team (PORT) cohort study. Arch. Intern. Med. 159, 970-80, 1999.
35. Ortqwist A. Antibiotic treatment of community-acquired pneumonia in clinical practice. J. Antimicrob. Chemoter. 35, 205-212, 1995.
36. De Lalla F., Eandi M. Indagine sull'uso di antibiotici nel trattamento delle infezioni delle basse vie respiratorie negli ospedali italiani: considerazioni farmacoeconomiche. Giornale Italiano Chemioterapia 6, 1-35, 1998.
37. Pozzi E., Concia E., Donner C.F., et al. Le polmoniti acquisite in comunità: modalità di gestione e di terapia. Medicina Toracica 21, 4, 1-12, 1999.
38. Guthrie R. Community acquired lower respiratory tract infections: etiology and treatment. Chest 120, 2021-2034, 2001.
39. Dean N.C., Silver M.P., Bateman K.A. et al. Decreased mortality after implementation of a treatment guidelines for community acquired pneumonia. Am. J. Med. 110, 451-457, 2001.
40. Zhanel G.G. The new fluoroquinolones: a critical rewiew. Can. J. Infect. Dis. 10, 207-238, 1999.
41. Halm E.A., Fine M.J., Kapoor W.N., Singer D.E., Marrie T.J., Siu A.L. Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia. Arch. Intern. Med. 162, 278-284, 2002.
42. Rhew D.C., Tu G.S., Ofman J., Henning J.M., Richards M.S., Weingarten S.R. Early switch and early discharge strategies in patients with community acquired pneumonia: a meta-analysis. Arch. Intern. Med. 161, 722-727, 2001.